Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 122

1.

Cost-effectiveness of statin therapy for primary prevention in a low-cost statin era.

Lazar LD, Pletcher MJ, Coxson PG, Bibbins-Domingo K, Goldman L.

Circulation. 2011 Jul 12;124(2):146-53. doi: 10.1161/CIRCULATIONAHA.110.986349. Epub 2011 Jun 27.

PMID:
21709063
[PubMed - indexed for MEDLINE]
Free Article
2.

Primary prevention of coronary heart disease with statins: it's not about the money.

Schwartz JS.

Circulation. 2011 Jul 12;124(2):130-2. doi: 10.1161/CIRCULATIONAHA.111.040329. No abstract available.

PMID:
21747064
[PubMed - indexed for MEDLINE]
Free Article
3.

Comparing impact and cost-effectiveness of primary prevention strategies for lipid-lowering.

Pletcher MJ, Lazar L, Bibbins-Domingo K, Moran A, Rodondi N, Coxson P, Lightwood J, Williams L, Goldman L.

Ann Intern Med. 2009 Feb 17;150(4):243-54.

PMID:
19221376
[PubMed - indexed for MEDLINE]
4.

Statins for cardiovascular prevention according to different strategies: a cost analysis.

Ito MK, Nanchen D, Rodondi N, Paccaud F, Waeber G, Vollenweider P, Marques-Vidal P.

Am J Cardiovasc Drugs. 2011;11(1):33-44. doi: 10.2165/11586760-000000000-00000.

PMID:
21265581
[PubMed - indexed for MEDLINE]
5.

Cost-effectiveness of cholesterol-lowering therapies according to selected patient characteristics.

Prosser LA, Stinnett AA, Goldman PA, Williams LW, Hunink MG, Goldman L, Weinstein MC.

Ann Intern Med. 2000 May 16;132(10):769-79.

PMID:
10819699
[PubMed - indexed for MEDLINE]
6.

Cost-effectiveness of HMG coenzyme reductase inhibitors; whom to treat?

van Hout BA, Simoons ML.

Eur Heart J. 2001 May;22(9):751-61.

PMID:
11350107
[PubMed - indexed for MEDLINE]
Free Article
7.

Statin cost effectiveness in primary prevention: a systematic review of the recent cost-effectiveness literature in the United States.

Mitchell AP, Simpson RJ.

BMC Res Notes. 2012 Jul 24;5:373. doi: 10.1186/1756-0500-5-373. Review.

PMID:
22828389
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Cost effectiveness of statin therapy for the primary prevention of major coronary events in individuals with type 2 diabetes.

Brandle M, Davidson MB, Schriger DL, Lorber B, Herman WH.

Diabetes Care. 2003 Jun;26(6):1796-801.

PMID:
12766112
[PubMed - indexed for MEDLINE]
9.

Cost effectiveness of HMG-CoA reductase inhibition in Canada.

Russell MW, Huse DM, Miller JD, Kraemer DF, Hartz SC.

Can J Clin Pharmacol. 2001 Spring;8(1):9-16.

PMID:
11283756
[PubMed - indexed for MEDLINE]
10.

Cost effectiveness of HMG-CoA reductase inhibitor (statin) treatment related to the risk of coronary heart disease and cost of drug treatment.

Pickin DM, McCabe CJ, Ramsay LE, Payne N, Haq IU, Yeo WW, Jackson PR.

Heart. 1999 Sep;82(3):325-32.

PMID:
10455083
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Cost-effectiveness of prescribing statins according to pharmaceutical benefits scheme criteria.

Lim SS, Vos T, Peeters A, Liew D, McNeil JJ.

Med J Aust. 2001 Nov 5;175(9):459-64.

PMID:
11758073
[PubMed - indexed for MEDLINE]
12.

[Primary prevention of coronary heart disease? What is cost effective in the clinical practice?].

Kübler W.

Z Kardiol. 2005;94 Suppl 3:III/92-9. German.

PMID:
16258799
[PubMed - indexed for MEDLINE]
13.

Cost effectiveness of statin therapy for the primary prevention of coronary heart disease.

Walshe V, Nash A, Barry M.

Ir Med J. 2006 May;99(5):144-5.

PMID:
16892920
[PubMed - indexed for MEDLINE]
14.

The cost effectiveness of statin therapies in Spain in 2010, after the introduction of generics and reference prices.

Plans-Rubió P.

Am J Cardiovasc Drugs. 2010;10(6):369-82. doi: 10.2165/11539150-000000000-00000.

PMID:
21090830
[PubMed - indexed for MEDLINE]
15.

Drug insight: Statin use in the elderly.

Raffel OC, White HD.

Nat Clin Pract Cardiovasc Med. 2006 Jun;3(6):318-28. Review.

PMID:
16729010
[PubMed - indexed for MEDLINE]
16.

Cost effectiveness of statins in coronary heart disease.

Franco OH, Peeters A, Looman CW, Bonneux L.

J Epidemiol Community Health. 2005 Nov;59(11):927-33. Review.

PMID:
16234419
[PubMed - indexed for MEDLINE]
Free PMC Article
17.
18.

Cost-effectiveness of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitor therapy in the managed care era.

Jacobson TA.

Am J Cardiol. 1996 Sep 26;78(6A):32-41.

PMID:
8875973
[PubMed - indexed for MEDLINE]
19.

Atorvastatin: a pharmacoeconomic review of its use in the primary and secondary prevention of cardiovascular events.

Plosker GL, Lyseng-Williamson KA.

Pharmacoeconomics. 2007;25(12):1031-53. Review.

PMID:
18047388
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk